1. Home
  2. ARMP vs HAIA Comparison

ARMP vs HAIA Comparison

Compare ARMP & HAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARMP
  • HAIA
  • Stock Information
  • Founded
  • ARMP N/A
  • HAIA 2021
  • Country
  • ARMP United States
  • HAIA United States
  • Employees
  • ARMP N/A
  • HAIA N/A
  • Industry
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • HAIA Blank Checks
  • Sector
  • ARMP Health Care
  • HAIA Finance
  • Exchange
  • ARMP Nasdaq
  • HAIA Nasdaq
  • Market Cap
  • ARMP 80.0M
  • HAIA 68.8M
  • IPO Year
  • ARMP N/A
  • HAIA 2021
  • Fundamental
  • Price
  • ARMP $1.98
  • HAIA $10.71
  • Analyst Decision
  • ARMP Strong Buy
  • HAIA
  • Analyst Count
  • ARMP 1
  • HAIA 0
  • Target Price
  • ARMP $7.00
  • HAIA N/A
  • AVG Volume (30 Days)
  • ARMP 9.2K
  • HAIA 1.7K
  • Earning Date
  • ARMP 11-13-2024
  • HAIA 01-01-0001
  • Dividend Yield
  • ARMP N/A
  • HAIA N/A
  • EPS Growth
  • ARMP N/A
  • HAIA N/A
  • EPS
  • ARMP N/A
  • HAIA N/A
  • Revenue
  • ARMP $5,467,000.00
  • HAIA N/A
  • Revenue This Year
  • ARMP N/A
  • HAIA N/A
  • Revenue Next Year
  • ARMP $83.33
  • HAIA N/A
  • P/E Ratio
  • ARMP N/A
  • HAIA N/A
  • Revenue Growth
  • ARMP 34.92
  • HAIA N/A
  • 52 Week Low
  • ARMP $1.97
  • HAIA $10.85
  • 52 Week High
  • ARMP $4.48
  • HAIA $11.75
  • Technical
  • Relative Strength Index (RSI)
  • ARMP 38.26
  • HAIA 13.37
  • Support Level
  • ARMP $1.97
  • HAIA $11.45
  • Resistance Level
  • ARMP $2.30
  • HAIA $11.59
  • Average True Range (ATR)
  • ARMP 0.11
  • HAIA 0.06
  • MACD
  • ARMP -0.02
  • HAIA -0.08
  • Stochastic Oscillator
  • ARMP 7.50
  • HAIA 0.00

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About HAIA Healthcare AI Acquisition Corp.

Healthcare AI Acquisition Corp is a blank check company.

Share on Social Networks: